Tudor Investment Corp
CMTA

Tudor Investment Corp’s Clementia Pharmaceuticals Inc. CMTA Stock Holding History

Tudor Investment Corp’s Portfolio CMTA Stock Details CMTA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q2 		– Sell
-412,077
Closed -$10.8M – 1470
2019
Q1 		$10.8M Buy
+412,077
New +$7.7M 0.44% 27
2017
Q4 		– Sell
-24,000
Closed -$405K – 1390
2017
Q3 		$405K Buy
+24,000
New +$392K 0.01% 720

Tudor Investment Corp's CMTA Position: Q2 2019 in Review

Tudor Investment Corp sold out of Clementia Pharmaceuticals Inc. (CMTA) in Q2 2019, closing a stake of 412,077 shares — an estimated $10.8M sold.

Tudor Investment Corp first reported a position in CMTA in Q3 2017 and held it in 2 quarters. The position peaked at $10.8M in Q1 2019. 0 funds tracked by Wall St. Rank hold CMTA as of Q2 2019.

  • Tudor Investment Corp reported no remaining Clementia Pharmaceuticals Inc. position as of Q2 2019 after selling out during the quarter.
  • Tudor Investment Corp sold 412,077 Clementia Pharmaceuticals Inc. shares in Q2 2019, an estimated $10.8M.
  • Tudor Investment Corp first reported a position in Clementia Pharmaceuticals Inc. in Q3 2017 and held it in 2 quarters.
  • Tudor Investment Corp's Clementia Pharmaceuticals Inc. position peaked at $10.8M in Q1 2019.
  • 0 funds tracked by Wall St. Rank held Clementia Pharmaceuticals Inc. as of Q2 2019.

Based on Tudor Investment Corp's 13F filing for Q2 2019, filed 14 Aug 2019.